Does Presbyterian Healthcare Services Cover Propecia?

What Presbyterian Healthcare Services Is and How Its Prescription Benefits Work

Presbyterian Healthcare Services is a New Mexico-based not-for-profit integrated health system and health plan serving both commercial members and Medicaid enrollees through Presbyterian Health Plan (PHP). Understanding how its pharmacy benefit works is the first step before asking whether any specific drug is covered.

Commercial vs. Medicaid Formularies

PHP operates separate formularies for its commercial, Medicare Advantage, and Medicaid (Centennial Care) lines of business. Each formulary assigns drugs to tiers. Tier 1 drugs carry the lowest copay; higher tiers carry larger cost-sharing or may require step therapy. Brand-name Propecia, when it appears at all, lands on Tier 3 or higher. Generic finasteride 1 mg has a better chance of appearing on Tier 1 or Tier 2, but placement is not guaranteed across all plan types.

The New Mexico Human Services Department contracts with PHP for Medicaid. Under federal Medicaid rules, states are not required to cover drugs whose primary indication is cosmetic. New Mexico's Medicaid drug policy broadly excludes treatments for cosmetic conditions, which typically sweeps in finasteride prescribed for androgenetic alopecia in men. Review the CMS Medicaid covered outpatient drugs guidance at the federal level; the state then layers on its own exclusions.

The Cosmetic Exclusion Problem

Most commercial health insurance contracts, including those sold by PHP, contain explicit cosmetic exclusion language. The American Academy of Dermatology distinguishes between alopecia areata (an autoimmune condition that may qualify for medical coverage) and androgenetic alopecia (genetic male pattern baldness, typically classified as cosmetic). The FDA approved finasteride 1 mg specifically for androgenetic alopecia, and that indication is what insurers use to trigger the cosmetic exclusion. The net result: even when the drug works and a physician recommends it, the payer classifies the underlying condition as cosmetic and denies coverage.

What the Clinical Evidence Says About Finasteride for Hair Loss

Before spending money on a drug, it helps to know whether the evidence actually supports it. The data for finasteride 1 mg are substantial.

The PLESS Trial and 5-Year Data

The key Phase III program that led to FDA approval included a 5-year controlled study. Men receiving finasteride 1 mg daily showed statistically significant increases in hair count at 1 year compared with placebo, and that benefit was maintained through 5 years while the placebo group continued to lose hair (Kaufman KD et al., JAAD 1998, PMID 9509480). This is one of the longest placebo-controlled trials in androgenetic alopecia research.

A 2019 systematic review and meta-analysis published in JAMA Dermatology (N = 1,879 participants across 30 trials) found finasteride produced significantly greater improvements in investigator-assessed hair growth than placebo, with a standardized mean difference of 0.95 (95% CI 0.72 to 1.17; P<0.001) (Adil A, Godwin M. JAMA Dermatol. 2017;153(10):1052.). The drug works. The insurance question is entirely separate from the efficacy question.

Mechanism of Action and Dosing

Finasteride is a 5-alpha reductase type II inhibitor. It blocks conversion of testosterone to dihydrotestosterone (DHT), the androgen responsible for miniaturizing hair follicles in genetically susceptible men. The standard dose for hair loss is 1 mg orally once daily. The 5 mg dose (Proscar) is approved for benign prostatic hyperplasia (BPH); some plans cover finasteride 5 mg for BPH but not finasteride 1 mg for alopecia, and some patients and prescribers use pill-splitting as a cost strategy, though this is an off-label practice patients should discuss with their physician.

Safety Profile

Sexual side effects (decreased libido, erectile dysfunction, ejaculatory disorders) occur in roughly 3.8% of finasteride 1 mg users versus 2.1% with placebo per prescribing information data (finasteride 1 mg full prescribing information, FDA). These effects are reversible in most men after stopping the drug. A small subset of men report persistent side effects; this remains under active investigation. The FDA added a post-marketing label update in 2012 noting reports of persistent sexual dysfunction.

How to Check Your Specific PHS Plan Coverage

Coverage questions have a definitive answer only when you look up your specific plan. Generic statements about what PHS "usually" does are a starting point, not a final answer.

Step 1: Find Your Formulary

Log into your Presbyterian Health Plan member portal at presbyterianhealthplan.org. Manage to "Prescription Drug Coverage" or "Formulary." Enter "finasteride" or "Propecia" in the drug search tool. The result will show you the tier, any restrictions (prior authorization, quantity limits, step therapy), and the applicable copay.

Alternatively, call the pharmacy benefit number printed on the back of your insurance card. Ask specifically: "Is finasteride 1 mg covered under my plan, and if so, what tier, what copay, and are there any coverage restrictions?"

Step 2: Understand Prior Authorization Requirements

Even when finasteride is on the formulary, PHP may require prior authorization (PA). A PA means your prescribing physician must submit clinical documentation showing the drug is medically necessary before the plan will pay. For androgenetic alopecia, PA approval is difficult to obtain because the cosmetic exclusion is already baked into the denial rationale. For conditions like alopecia areata or post-chemotherapy alopecia, a PA with proper diagnosis coding has a better approval probability.

Your physician's office can submit the PA request. Ask them to use ICD-10 code L64.9 (androgenic alopecia, unspecified) or, if applicable, L63.9 (alopecia areata, unspecified). The distinction matters enormously for coverage decisions.

Step 3: Request a Coverage Determination in Writing

If the phone representative says finasteride is not covered, request a formal Adverse Coverage Determination letter. This starts the official appeals clock. Under ACA rules applicable to commercial plans, you have the right to a first-level internal appeal and, if denied, an external review by an independent organization. New Mexico's Office of the Superintendent of Insurance oversees external review for state-regulated plans.

The Appeals Process for Denied Finasteride Claims

Denials are not automatically the end of the road. A structured appeal has a measurable success rate, particularly when additional clinical documentation is provided.

Internal Appeal

File within the timeframe stated in your denial letter (typically 180 days for commercial plans under ERISA). Your physician should submit:

• A letter of medical necessity explaining the clinical rationale
• Documentation of the diagnosis and its impact on psychological well-being (depression and anxiety comorbidity with alopecia is well-documented in the literature; one systematic review found anxiety and depression were significantly more prevalent in men with androgenetic alopecia than in controls (Hoss D, Segal S. Psychosom Med. 1998;60(4):512 to 519.))
• Any relevant photographs or dermatologist assessment

External Review

If the internal appeal is denied and the plan is subject to ACA external review requirements (most commercial plans are), you can request that the state's independent review organization examine the case. This adds time (up to 45 days for standard external review, 72 hours for expedited), but external reviewers sometimes overturn cosmetic exclusions when the treating physician documents psychological or functional impairment.

What Finasteride Actually Costs Without Insurance

If coverage is denied and appeals fail, the cost question becomes urgent. Knowing the real numbers helps you decide whether to pay out-of-pocket or pursue alternatives.

Brand Propecia Pricing

Brand-name Propecia 1 mg, 30 tablets, retails for approximately $70 to $120 per month at major pharmacy chains without insurance. Over 12 months that is $840 to $1,440 annually. Most men who respond to finasteride need to take it indefinitely because hair re-lost within 12 months of stopping the drug.

Generic Finasteride Pricing

Generic finasteride 1 mg is dramatically cheaper. GoodRx and similar discount programs routinely list prices of $10 to $30 per month at pharmacies including Walgreens, CVS, Walmart, and Costco. At some warehouse pharmacies, 90-day supplies run under $20 total. The FDA approved the first generic finasteride 1 mg in 1998; multiple manufacturers now produce it, keeping prices competitive (FDA generic drug approval records).

FSA and HSA Eligibility

Prescription finasteride may qualify as an FSA- or HSA-eligible expense because it requires a prescription. The IRS does not automatically exclude cosmetically classified drugs from FSA/HSA reimbursement if a valid prescription exists. Confirm eligibility with your FSA/HSA plan administrator before submitting claims.

Alternatives to Propecia That PHS May Cover

When finasteride for androgenetic alopecia is excluded, patients and prescribers sometimes pivot to strategies that have different coverage logic.

Minoxidil (Topical)

Topical minoxidil 2% and 5% solutions and foam are available over the counter. No prescription is needed, so no insurance is involved. A month's supply runs $15 to $30. The combination of finasteride and minoxidil produces additive benefit; a 48-week study published in Dermatologic Therapy found the combination superior to either agent alone in men with androgenetic alopecia (Hu R et al. Dermatol Ther. 2015;28(5):312 to 316.). For men who cannot afford finasteride, minoxidil alone is a reasonable starting point.

Oral Minoxidil (Low-Dose)

Low-dose oral minoxidil (0.25 mg to 2.5 mg daily) has gained significant traction as an off-label treatment. A 2022 review in the Journal of the American Academy of Dermatology covering 17 studies and more than 600 patients reported good efficacy and tolerability at these doses (Randolph M, Tosti A. J Am Acad Dermatol. 2021;84(3):737 to 746.). Because oral minoxidil is prescribed off-label for alopecia, its formulary status is variable; some plans cover it because the drug itself (at higher doses) has a cardiac indication.

Finasteride 5 mg (BPH Indication) with a BPH Diagnosis

Men who also carry a documented diagnosis of benign prostatic hyperplasia may find that finasteride 5 mg (Proscar) is covered under the BPH indication. The prescribing physician would need to document both diagnoses. This is a legitimate clinical path when the patient genuinely has BPH, not a workaround fabricated solely for insurance purposes.

Dutasteride

Dutasteride 0.5 mg (Avodart), a dual 5-alpha reductase inhibitor, is FDA-approved for BPH and has demonstrated efficacy for androgenetic alopecia in randomized trials, though it is not FDA-approved for that indication in the United States. Coverage under a BPH diagnosis follows similar logic to finasteride 5 mg. A 24-week Phase III trial (N = 917) showed dutasteride 0.5 mg produced significantly greater increases in total hair count compared with finasteride 1 mg in Asian men with androgenetic alopecia (Tsunemi Y et al. J Dermatol. 2016;43(9):1018 to 1022.).

Telehealth and Compounding Options

The rise of telehealth hair-loss platforms has changed the cost math for many men. Several platforms prescribe generic finasteride and compound topical formulations (finasteride plus minoxidil in a single topical solution) at prices that undercut retail pharmacy even without insurance.

The HealthRX clinical team uses a structured coverage-and-cost decision framework for patients asking about finasteride. The framework works in four steps:

1. Check the PHS formulary for generic finasteride 1 mg first, not brand Propecia.
2. If the generic is covered but PA is required, have your physician document any psychological comorbidity (PHQ-9 score, dermatologist assessment) to support the PA.
3. If coverage is denied, compare the generic cash price at GoodRx-discounted pharmacies against telehealth subscription prices before assuming the plan is the best path.
4. If cost remains a barrier after step 3, evaluate low-dose oral minoxidil or topical combination products as a covered or OTC alternative while re-attempting a formal appeal.

This four-step approach reduces the time most patients spend navigating coverage by focusing first on the lowest-friction path to the drug.

The Role of Your Prescribing Physician

A physician who understands insurance coding can materially affect your coverage outcome. Several practical steps make a difference.

Diagnosis Coding Precision

ICD-10 code selection matters. L64.9 (androgenic alopecia, unspecified) reliably triggers the cosmetic exclusion in most plans. If your dermatologist documents L63.9 (alopecia areata) or L66.1 (lichen planopilaris) based on actual clinical findings, the coverage pathway changes. Do not pressure your physician to misrepresent the diagnosis; instead, ask whether any component of your presentation fits a diagnosis that carries different coverage logic.

The American Academy of Dermatology Position

The American Academy of Dermatology (AAD) guidelines on androgenetic alopecia state that finasteride 1 mg daily is an FDA-approved, evidence-based first-line treatment for male pattern hair loss (Kanti V et al. J Am Acad Dermatol. 2018;78(6):1031 to 1044.). The AAD guidelines do not classify the condition as purely cosmetic; they note the significant psychosocial burden of hair loss. A physician who cites these guidelines in a prior authorization or appeal letter provides the plan's medical director with authoritative clinical context that may tip a borderline decision.

As noted in the AAD guidelines: "Finasteride is the only oral agent approved by the FDA for male androgenetic alopecia and has level I evidence supporting its use for this indication."

What Happens If You Stop Taking Finasteride

One consideration that affects the cost-benefit calculation: stopping finasteride causes the hair re-gained or preserved during treatment to shed within 9 to 12 months. This is not a withdrawal effect in the pharmacological sense but simply the return of DHT-driven follicle miniaturization once the drug is gone. A 1-year post-treatment follow-up from the original Phase III program showed men who discontinued after 1 year of treatment lost the hair they had gained by month 12 post-discontinuation (Kaufman KD et al. JAAD 1998). Patients need to understand this before starting therapy, particularly if coverage is uncertain and cost sustainability is a concern.

Practical Checklist: Navigating PHS Coverage for Finasteride

Below is a direct action list for PHS members asking this question.

• Call PHP member services (800-356-2219 for most commercial plans) and request a formulary lookup for finasteride 1 mg.
• Ask your dermatologist or primary care physician to submit a prior authorization with diagnosis code specificity and psychological burden documentation.
• Obtain a GoodRx price at your local pharmacy for comparison before assuming insurance is the cheaper path.
• If denied, request the Adverse Coverage Determination letter and file an internal appeal within 180 days.
• If the internal appeal is denied, request external review through New Mexico's Office of the Superintendent of Insurance.
• Ask your physician whether you meet clinical criteria for a BPH diagnosis that would support finasteride 5 mg coverage.
• Confirm FSA/HSA eligibility for a prescription finasteride purchase if self-pay is the final path.